However, among patients with CYBB deficiency, those with LO-mIBD had higher response rates to 5-aminosalicylic acid (5-ASA, 100.0% vs. 33.3%) and glucocorticoids (GCS, 100.0% vs. 66.7%) than those with IO-mIBD, although the difference did not reach significance (p > 0.05). The gene discussed is CYBB; the disease is hyperinsulinemic hypoglycemia, familial, 4.